Particularly, compound 4 has demonstrated significant therapeutic potential against various cancer types, exhibiting inhibitory and anti-proliferation characteristics that are comparable to, if not better than, existing WEE1 inhibitors. This evidence concerns the gene WEE1 and cancer.